Sunday, October 11, 2026

PACCAR Stock Is 28% Down In The Last 21 Sessions

ViaNews Editorial Team

February 22, 2023

PACCAR Stock Is 28% Down In The Last 21 Sessions

(VIANEWS) - Shares of PACCAR (NASDAQ: PCAR) fell by a staggering 28.58% in 21 sessions from $102.25 at 2023-01-23, to $73.03 at 16:13 EST on Wednesday, following the last session's downward trend. NASDAQ is sliding 0.02% to $11,489.83, after three sequential sessions in a row of losses.

PACCAR's last close was $73.86, 2.97% below its 52-week high of $76.12.

About PACCAR

PACCAR Inc designs, manufactures, and distributes light, medium, and heavy-duty commercial trucks in the United States, Europe, Mexico, South America, Australia, and internationally. It operates through three segments: Truck, Parts, and Financial Services. The Truck segment designs, manufactures, and distributes trucks for the over-the-road and off-highway hauling of commercial and consumer goods. It sells its trucks through a network of independent dealers under the Kenworth, Peterbilt, and DAF nameplates. The Parts segment distributes aftermarket parts for trucks and related commercial vehicles. The Financial Services segment conducts full-service leasing operations under the PacLease trade name, as well as provides finance and leasing products and services to customers and dealers. This segment also offers equipment financing and administrative support services for its franchisees; retail loan and leasing services for small, medium, and large commercial trucking companies, as well as independent owners/operators and other businesses; and truck inventory financing services to independent dealers. In addition, this segment offers loans and leases directly to customers for the acquisition of trucks and related equipment. The company also manufactures and markets industrial winches under the Braden, Carco, and Gearmatic nameplates. PACCAR Inc was founded in 1905 and is headquartered in Bellevue, Washington.

Earnings Per Share

As for profitability, PACCAR has a trailing twelve months EPS of $4.06.

PE Ratio

PACCAR has a trailing twelve months price to earnings ratio of 17.98. Meaning, the purchaser of the share is investing $17.98 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 24.48%.

Growth Estimates Quarters

The company's growth estimates for the current quarter and the next is 47.8% and 23.2%, respectively.

Revenue Growth

Year-on-year quarterly revenue growth grew by 21.6%, now sitting on 28.82B for the twelve trailing months.

Volatility

PACCAR's last week, last month's, and last quarter's current intraday variation average was a negative 0.48%, a positive 0.54%, and a positive 1.17%.

PACCAR's highest amplitude of average volatility was 1.21% (last week), 1.46% (last month), and 1.17% (last quarter).

Yearly Top and Bottom Value

PACCAR's stock is valued at $73.03 at 16:13 EST, below its 52-week high of $76.12 and way higher than its 52-week low of $51.33.

More news about PACCAR (PCAR).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Agentic AI Rewires Enterprise Software: Platform Incumbents, Governance, and a Funded Startup Wave
Enterprise software is being rebuilt around autonomous AI agents. Incumbents and large platforms (SAP with its Autonomous Suite and Joule, Zeta with AthenaOS/AIM/Athena MCP, Meta with its new Enterprise Platform) are racing to own the agent layer. Meanwhile, seed and Series A money flows to finance-office and vertical startups (Dextr, Latitude, Dentira, Light), and consolidation continues through acquisitions (Tiny–Oso Cloud, Harvey–Guardrails AI). Investor commentary stresses that AI is better at disrupting around the edges of systems of record than at replacing them, that it should not be trusted with finance calculations, and that governance must be enforced by the system rather than left to agents.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,369 source documents archived
Query this data → isubstrate.com